Powered by

HistoSonics' tech attracts health care heavyweights

Apr 08, 2019 - Crain's Detroit Business
Investments

Ann Arbor-based HistoSonics Inc. plans to announce Monday that it has closed on a venture-capital funding round of $54 million for its ultrasound therapy that destroys cancer tumors.

The investment led by two health care heavyweights is believed to be the second-largest funding round for a medical-device company in state history.

The two new investors who led the Series C funding may be as important as the size of the round - Varian Medical Systems of Palo Alto, Calif., the global le...